-transparent.png){kind=logo}
Miconazole was injected intravenously in six patients with coccidioidomycosis. Two patients received 101 and 185 g, respectively, without clinical response and with persistence of positive cultures for Coccidioides immitis. In one patient, symptoms were suppressed when amphotericin B was given with miconazole, but new lesions developed with miconazole alone (total dose, 963 g). Three patients received smaller doses: 30.6 g before death from an unrelated complication; 17 and 22.3 g before development of severe allergic reactions. Because of the high rate of initial failures and relapses, miconazole is not recommended as primary therapy for coccidioidomycosis.
Related Publications
P D Hoeprich, and
R M Lawrence, and
E Goldstein
January 1976,
The Western journal of medicine,
P D Hoeprich, and
R M Lawrence, and
E Goldstein
October 1983,
Drugs,
P D Hoeprich, and
R M Lawrence, and
E Goldstein
January 1977,
Proceedings of the Royal Society of Medicine,
P D Hoeprich, and
R M Lawrence, and
E Goldstein
April 1977,
The Western journal of medicine,
P D Hoeprich, and
R M Lawrence, and
E Goldstein
June 1978,
Chest,
P D Hoeprich, and
R M Lawrence, and
E Goldstein
November 1974,
JAMA,
P D Hoeprich, and
R M Lawrence, and
E Goldstein
November 1979,
The American review of respiratory disease,
P D Hoeprich, and
R M Lawrence, and
E Goldstein
August 1979,
Chest,
P D Hoeprich, and
R M Lawrence, and
E Goldstein
January 1978,
Medecine & chirurgie digestives,
P D Hoeprich, and
R M Lawrence, and
E Goldstein
December 1979,
Clinical and experimental dermatology,
